Cargando…
CPSF4 promotes triple negative breast cancer metastasis by upregulating MDM4
Autores principales: | Lee, Kaping, Zheng, Qiufan, Lu, Qianyi, Xu, Fei, Qin, Ge, Zhai, Qinglian, Hong, Ruoxi, Chen, Miao, Deng, Wuguo, Wang, Shusen |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8131696/ https://www.ncbi.nlm.nih.gov/pubmed/34006850 http://dx.doi.org/10.1038/s41392-021-00565-9 |
Ejemplares similares
-
Clinical genomic profiling to identify actionable alterations for very early relapsed triple-negative breast cancer patients in the Chinese population
por: Wang, Liye, et al.
Publicado: (2021) -
Identification and characterization of critical genes associated with tamoxifen resistance in breast cancer
por: Zhang, Kai, et al.
Publicado: (2020) -
Construction and validation of a macrophage polarization-related prognostic index to predict the overall survival in patients with early-stage triple-negative breast cancer
por: Luo, Hanjia, et al.
Publicado: (2023) -
Metronomic chemotherapy of cyclophosphamide plus methotrexate for advanced breast cancer: Real‐world data analyses and experience of one center
por: Lu, Qianyi, et al.
Publicado: (2020) -
Local treatment for liver oligometastases in breast cancer patients: identification of prognostic factors and exploration of appropriate treatment strategy
por: Jiang, Kuikui, et al.
Publicado: (2020)